Hot Features
Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment of orphan oncology indications in the United States. The company develops antisense and small molecule injectable drugs for the treatment of cancer. It is also developing O... Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment of orphan oncology indications in the United States. The company develops antisense and small molecule injectable drugs for the treatment of cancer. It is also developing OXi4503 for the treatment of acute myeloid leukemia and myelodysplastic syndromes; OT-101, an antisense against TGF-ß2, which is in phase 3 clinical trials for pancreatic cancer, melanoma, and glioblastoma, as well as for the treatment of various viruses, including severe acute respiratory syndrome and coronavirus. In addition, the company develops CA4P for the treatment of advanced metastatic melanoma; AL-101, an intranasal drug and delivery system for intra-nasal apomorphine for the treatment of parkinson’s disease, erectile disfunction, and female sexual disfunction; Artemisinin, a natural derivative from an Asian herb Artemisia Annua; and AI based technologies to enhance the development and commercialization of support technologies, as well as nanoparticle products for the treatment of various cancers. The company is based in Agoura Hills, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.01375 | -22.4489795918 | 0.06125 | 0.06125 | 0.037 | 252163 | 0.05141755 | CS |
| 4 | 0.009 | 23.3766233766 | 0.0385 | 0.062 | 0.036 | 383793 | 0.05007364 | CS |
| 12 | 0.0075 | 18.75 | 0.04 | 0.062 | 0.0294 | 317953 | 0.04219546 | CS |
| 26 | -0.0431 | -47.5717439294 | 0.0906 | 0.101 | 0.015 | 270938 | 0.04949275 | CS |
| 52 | -0.01225 | -20.5020920502 | 0.05975 | 0.11 | 0.015 | 240890 | 0.0620595 | CS |
| 156 | 0.0165 | 53.2258064516 | 0.031 | 0.11 | 0.01 | 189884 | 0.04414639 | CS |
| 260 | -0.2315 | -82.9749103943 | 0.279 | 0.28 | 0.01 | 189725 | 0.07594435 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.